MENU

Can Cognex (CGNX) Stock Reach $80?

a manufacturer of machine vision computer systems

CGNX
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
Sep 02, 2026

Can Cognex (CGNX) Stock Reach $80?

Key Takeaways

  • The $80 price target represents roughly 33% upside from Cognex's recent share price near $60 and sits just above its 52-week high of $72.88.
  • The strongest bullish case rests on an AI-enabled machine vision product cycle, rapidly improving margins, and a recovery in key industrial end markets.
  • The biggest obstacles are an elevated valuation, a cyclical customer base, and near-term headwinds from difficult quarterly comparisons.
  • The $72.88 prior high is the key resistance level to clear, while the low-to-mid $50s area has historically provided support.
  • Analyst consensus clusters around $75–$80, suggesting the target is plausible but dependent on sustained execution.

Why Investors Are Watching the $80 Level

Cognex Corporation (NASDAQ: CGNX), a leading provider of machine vision systems used to automate manufacturing and logistics, has become a focal point for investors betting on the intersection of artificial intelligence and industrial automation. The $80 mark carries particular weight because it aligns closely with the consensus analyst price target while also sitting just above the stock's 52-week high of $72.88. Clearing that previous peak would first be required before the shares could make a meaningful run toward $80.

Company Overview and Current Market Position

Cognex designs smart cameras, barcode readers, and vision software that help factories and warehouses inspect parts, guide robots, and track products. The company generates the bulk of its revenue from the Americas, Europe, and Greater China. After a challenging stretch in 2023, when revenue fell roughly 17%, the business has returned to growth, with fiscal 2025 revenue climbing about 9% to just under $995 million. More recently, second-quarter 2026 revenue rose 17% year over year to $291.3 million, while gross margin expanded to 71% from 67% a year earlier. The company also holds a strong balance sheet, with roughly $755 million in cash and investments and essentially no net debt.

What Could Drive the Next Leg Higher

Several factors support the case that CGNX can climb toward $80. First, the company is entering what analysts describe as a new product cycle built around AI-enabled vision systems. Its OneVision platform, a cloud-to-edge AI vision development tool for manufacturing inspection, has been tested by more than 100 customers and positions Cognex to capture demand as factories modernize. Second, operating leverage is improving rapidly, with management guiding toward adjusted EBITDA margins in the high-20% range — a meaningful expansion from earlier levels. Third, Greater China revenue jumped 47% in the most recent quarter, signaling a recovery in one of the company's historically volatile but important markets. Finally, an additional $500 million share repurchase authorization gives management a tool to support the stock.

What Could Prevent the Move

The path to $80 is not without obstacles. Cognex trades at a price-to-earnings ratio near 59 on trailing earnings, a premium multiple that leaves little room for disappointment. Its customer base is cyclical, and management itself has cautioned that the third quarter faces difficult comparisons and a pull-forward of electronics demand into the second quarter. A slowdown in factory automation spending, renewed weakness in China, or a broader industrial downturn could stall the recovery. Because much of the recent strength is already reflected in estimates — analysts have been raising earnings forecasts — the stock could react negatively to any sign that margin expansion or revenue growth is decelerating.

Analyst Opinions and Price Targets

Wall Street's view is broadly constructive. The consensus rating on Cognex is a "Buy" or "Overweight," with average twelve-month price targets generally ranging between roughly $71 and $80 depending on the data source, and a high estimate near $94. Several firms — including Goldman Sachs, Barclays, and KeyBanc — have set targets at or near $80, while J.P. Morgan upgraded the stock to Overweight citing AI-enabled vision systems and a doubling of the customer base through a salesforce transformation. At the same time, a handful of analysts maintain Hold ratings with lower targets in the $65–$78 range, reflecting caution about valuation and the timing of the industrial recovery. The spread between those views underscores that $80 is achievable but far from guaranteed.

Technical Levels That Matter

From a technical perspective, $80 functions as a psychological round-number objective that also matches the upper band of analyst targets. Before that level can be tested, the shares must first reclaim and hold above the 52-week high of $72.88, which now acts as the primary resistance zone. On the downside, the stock's 52-week low of $34.60 is far removed from current levels, but the low-to-mid $50s area has served as a support zone during recent pullbacks. The long-term trend remains constructive after a powerful rally from the 2025 lows, though the stock's high beta — around 1.5 — means it tends to amplify both sector rallies and selloffs.

AI Daily Buy/Sell Signals

Traders seeking a more systematic way to monitor changing conditions can turn to AI Daily Buy/Sell Signals. This tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. By surfacing opportunities and flagging shifting trends more efficiently than manual review, it can help traders discover new setups, monitor existing positions, and respond to changing momentum as it develops.

Final Assessment

The question of whether Cognex can reach $80 ultimately hinges on execution rather than a single catalyst. The fundamental backdrop is supportive: AI-enabled vision products, expanding margins, a recovering China market, and a clean balance sheet all argue that the target is realistic within the next twelve months, and a majority of analysts appear to agree. The primary risks are valuation and cyclicality — a premium multiple combined with exposure to a cyclical industrial customer base means any stumble could delay or derail the move. Investors should monitor quarterly revenue growth, gross and operating margin trends, the durability of the China recovery, and whether the shares can decisively clear the $72.88 level. A sustained breakout above that prior high would materially improve the odds that $80 becomes the next milestone, while a failure to hold support in the mid-$50s would suggest the rally needs more time.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
CGNX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CGNX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CGNX has been loosely correlated with MKSI. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGNX jumps, then MKSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGNX
1D Price
Change %
CGNX100%
+4.10%
MKSI - CGNX
50%
Loosely correlated
+2.09%
ST - CGNX
45%
Loosely correlated
+3.44%
VNT - CGNX
42%
Loosely correlated
+2.91%
NOVT - CGNX
39%
Loosely correlated
+1.84%
VPG - CGNX
39%
Loosely correlated
+5.91%
More
Can Cognex (CGNX) Stock Reach $80?